The DOI matches its Crossref record.
Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey
Abstract
Using a nationally representative sample, this study examines the disease-specific impairments of DSM-IV generalized anxiety disorder (GAD) by comparing them to the impairments associated with major depressive disorder (MDD). Results are based on 4181 respondents between the ages of 18-65 years who were interviewed with the 12-month version of the Munich-Composite International Diagnostic Interview as part of the German National Health Interview and Examination Survey-Mental Health Supplement (GHS). After controlling for age, gender, and other psychopathology, 'pure' current GAD without MDD (n = 33), pure MDD (n = 344) and comorbid GAD and MDD (n = 40) were each associated with high impairment as defined by poor self-perceived health, at least 3 days limited or impaired in the past month, and low quality of life scores [from the Short Form-36 Health Survey (SF-36)]. Quality of life scores on several of the SF-36 scales were significantly lower for respondents with pure GAD as compared to respondents with pure MDD. Overall, the results show that DSM-IV GAD is associated with high impairment even after controlling for other psychopathology. The impairment outcomes for GAD were comparable in size to those for MDD. These findings underline the significance of this disorder from a clinical and social perspective and provide support for the independent diagnostic status of GAD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“generalized anxiety disorder (GAD) is a actually a chronic and debilitating condition that is associated with diminished impairment equivalent to major depressive disorder (MDD3), poorer life quality than MDD when only non-comorbid cases are compared between the two disorders4, and independent associations with negative functional outcomes when both disorders are comorbid5.”
Citations
Cites
Still being checked.
Cited by
Löwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., & Herzberg, P. Y. (2008) · Medical Care · doi:10.1097/mlr.0b013e318160d093 · Cited by 4,527
Salk, R. H., Hyde, J. S., & Abramson, L. Y. (2017) · Psychological Bulletin · doi:10.1037/bul0000102 · Cited by 2,622
Löwe, B., Wahl, I., Rose, M., Spitzer, C., Glaesmer, H., Wingenfeld, K., Schneider, A., & Brähler, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.019 · Cited by 2,473
Transdiagnostic approaches to mental health problems: Current status and future directions.
Dalgleish, T., Black, M., Johnston, D., & Bevan, A. (2020) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000482 · Cited by 883
Quality of life in the anxiety disorders: a meta-analytic review
Olatunji, B. O., Cisler, J. M., & Tolin, D. F. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.01.015 · Cited by 808
Metadata
- Authors
- Wittchen, H.-U., Carter, R. M., Pfister, H., Montgomery, S. A., & Kessler, R. C.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Imperial College London (GB)
- Harvard University (US)
- Venue
- International Clinical Psychopharmacology
- Published
- 2000-11
- Volume
- 15
- Issue
- 6
- Pages
- 319-328
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W1980777750
- Cited by
- 299
- References
- 0
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 8 · 2023: 8 · 2022: 4 · 2021: 24 · 2020: 6 · 2019: 5 · 2018: 9 · 2017: 9 · 2016: 15 · 2015: 17 · 2014: 12 · 2013: 15 · 2012: 11
- FWCI
- 17.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Keywords
- generalized anxiety disorder, major depressive disorder, comorbidities, quality of life, functional disability, health perception, SF-36, DSM-IV
- MeSH terms
- Adolescent, Adult, Aged, Agoraphobia, Cross-Sectional Studies, Depressive Disorder, Disability Evaluation, Female, Germany, Health Surveys, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Quality of Life, Comorbidity, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. https://app.cochat.ai/papers/10.1097/00004850-200015060-00002
- The paper
- Wittchen, H.-U., Carter, R. M., Pfister, H., Montgomery, S. A., & Kessler, R. C. (2000). Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-200015060-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.